GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (WBO:ABBV) » Definitions » Market Cap

AbbVie (WBO:ABBV) Market Cap : €268,754 Mil (As of Apr. 30, 2024)


View and export this data going back to 2018. Start your Free Trial

What is AbbVie Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). AbbVie's share price for the quarter that ended in Dec. 2023 was €139.7. AbbVie's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 1,766 Mil. Therefore, AbbVie's market cap for the quarter that ended in Dec. 2023 was €246,702 Mil.

AbbVie's quarterly market cap increased from Jun. 2023 (€217,953 Mil) to Sep. 2023 (€251,582 Mil) but then declined from Sep. 2023 (€251,582 Mil) to Dec. 2023 (€246,702 Mil).

AbbVie's annual market cap increased from Dec. 2021 (€210,539 Mil) to Dec. 2022 (€269,623 Mil) but then declined from Dec. 2022 (€269,623 Mil) to Dec. 2023 (€246,702 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. AbbVie's Enterprise Value for Today is €312,214 Mil.


AbbVie Market Cap Historical Data

The historical data trend for AbbVie's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Market Cap Chart

AbbVie Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 118,312.80 150,600.89 210,538.56 269,623.03 246,701.82

AbbVie Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 256,410.68 217,952.80 251,582.33 246,701.82 297,115.07

Competitive Comparison of AbbVie's Market Cap

For the Drug Manufacturers - General subindustry, AbbVie's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AbbVie's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AbbVie's Market Cap distribution charts can be found below:

* The bar in red indicates where AbbVie's Market Cap falls into.



AbbVie Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

AbbVie's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€139.7*1765.94
=€246,702

AbbVie's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=€139.7*1765.94
=€246,702

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AbbVie  (WBO:ABBV) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


AbbVie Market Cap Related Terms

Thank you for viewing the detailed overview of AbbVie's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


AbbVie (WBO:ABBV) Business Description

Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

AbbVie (WBO:ABBV) Headlines